Our analysis revealed a notable mutually exclusive pattern in the genomic alteration status between ELAVL2 and NF1 (Supplementary Fig. 1e), suggesting the potential mechanistic role of ELAVL2 in driving MES transition in GBM. The gene discussed is NF1; the disease is glioblastoma.